← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Rochester General Hospital (Ny)
Rochester, NY
$8,220,534
Total funding
9
Grants
Funding over time
peak $1.2M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,220,534 · 9
By mechanism
R01$5,215,589 · 2
U01$1,616,462 · 1
R03$678,483 · 4
R21$440,000 · 1
K22$270,000 · 1
Investigators at Rochester General Hospital (Ny)
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Largest grants
A Phase II Study Evaluating the Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp) in Reducing Nasopharyngeal Colonization by Streptococcus pneumoniae in Young Children$822,233
U01 · FY2024 · AI
A Phase II Study Evaluating the Safety and Efficacy of Whole-Cell Pneumococcal Vaccine (wSp) in Reducing Nasopharyngeal Colonization by Streptococcus pneumoniae in Young Children$794,229
U01 · FY2025 · AI
Immune Responses in Otitis Prone Children$642,800
R01 · FY2015 · DC
Immune Responses in Otitis Prone Children$587,036
R01 · FY2012 · DC
Immune Responses in Otitis Prone Children$585,306
R01 · FY2016 · DC
Immune Responses in Otitis Prone Children$557,036
R01 · FY2014 · DC
Immune Responses in Otitis Prone Children$529,185
R01 · FY2013 · DC
NTHi Immunity in Young Children$508,772
R01 · FY2009 · DC
NTHi Immunity in Young Children$491,882
R01 · FY2010 · DC
NTHi Immunity in Young Children$469,017
R01 · FY2011 · DC
Haemophilus influenzae lipoprotein fusion vaccine and lipoprotein vaccine platform development$404,539
R01 · FY2025 · AI
NTHi Immunity in Young Children$309,776
R01 · FY2009 · DC
Enhanced immunogenicity and protection study of lipid modified protein vaccine candidates of Nontypeable Haemophilus influenzae$240,000
R21 · FY2020 · AI
Enhanced immunogenicity and protection study of lipid modified protein vaccine candidates of Nontypeable Haemophilus influenzae$200,000
R21 · FY2021 · AI
Analysis of Pro-inflammatory Memory CD4 T-cell Subsets to Influenza Infection$162,000
K22 · FY2010 · AI
Analysis of Pro-inflammatory Memory CD4 T-cell Subsets to Influenza Infection$108,000
K22 · FY2011 · AI
Immune biomarker discovery in children susceptible to recurrent otitis media$89,717
R03 · FY2021 · AI
Immunogenicity of Moraxella catarrhalis vaccine candidates in children$86,955
R03 · FY2016 · AI
Immunogenicity of Moraxella catarrhalis vaccine candidates in children$86,758
R03 · FY2015 · AI
Immune biomarker discovery in children susceptible to recurrent otitis media$85,182
R03 · FY2022 · AI